Skip to search formSkip to main contentSkip to account menu

diisopropyl 1,3-dithiol-2-ylidenemalonate

Known as: 1,3-dithiol-2-ylidenepropanedioic acid, bis(1-methylethyl) ester, malotilate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
Therapeutic attempts with anti-fibrotic drugs are still at an experimental stage. The clinical efficacies of most agents listed… 
Review
1990
Review
1990
Although there is no established therapy for the fibrogenesis of hepatic cirrhosis, many potential therapies are now emerging… 
1987
1987
Malotilate is a new drug suggested for use in chronic liver diseases. It is shown here to prevent liver damage caused by CCl4… 
1987
1987
The effect of malotilate (diisopropyl 1,3-dithiol-2-ylidenemalonate) on drug metabolizing activity in rat liver microsomes was… 
1982
1982
The effect of malotilate (diisopropyl 1,3-dithiol-2-ylidenemalonate) on the protein synthesis in rat liver was studied in vivo… 
1982
1982
The relationship between the changes in the amount of the components of the liver microsomal electron transport systems and drug… 
1981
1981
The therapeutic effect of diisopropyl 1,3-dithiol-2-ylidenemalonate (NKK-105) on the fatty liver induced by carbon tetrachloride… 
1980
1980
Effect of diisopropyl 1,3-dithiol-2-ylidenemalonate (NKK-105) on the components of rat liver microsomal electron transport system…